Items Tagged ‘Niaspan’

November 18, 2009

AHA: ARBITER 6-HALTS — Are There Any Clinical Implications?

By Kelley Luckstein KelleyLuckstein

By a margin of 0.014 mm in carotid intima-media thickness (CIMT), extended-release niacin (Niaspan) demonstrated superiority over ezetimibe (Zetia) as an add-on for high risk patients on long term statin therapy…   Stephen Kopecky, MD, a cardiologist at the Mayo Clinic, in Rochester, Minn., said there was no doubt that “surrogate endpoints are being overused. […]

View full entry

Tags: AHA, Niaspan, Zetia


Contact Us · Privacy Policy